Atlas Trials

Effect of Sublingual Fentanyl on Breathlessness in COPD

Clinical trial NCT04004117 · TERMINATED

Trial details

NCT number
NCT04004117
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Status
TERMINATED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Copd
Start date
2019-07-01
Primary completion
2019-12-31
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.